Hepatic and Cardiac Metabolic Flexibility in Obese With NAFLD.
The Effect of Physical Activity on the Liver and the Heart's Metabolism of Fatty Acids in Obese With and Without NAFLD
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Aarhus N
-
Skejby, Aarhus N, Denmark, 8200
- Department of Diabetes and Hormone diseases in Aarhus University Hopital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 10 obese subject men/women with NAFLD (MR spectroskopi, fibro scanner) (BMI > 30).
- 10 obese subject men/women without NAFLD (MR spectroskopi, fibro scanner) (BMI > 30).
- age between 40-70 years
- Written consent before the start of the study
Exclusion Criteria:
- known current disease
- Fixed Medical drug consumption, statins and antihypertensive drugs (non-beta blocker). However, pause 3 weeks before the examination date
- Blood donation within the last 3 months prior to the study
- Participation in experiments involving radioactive isotopes within the last 6 months
- Alcohol abuse (over 21 items per week for men and 14 for women)
- Smoking
- Weight over 130 kg
- Cancer patients
- Large intake of medication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Healthy male volunteers
Behavioral: Exercise Moderate Intensity Exercise (50 % af VO2max) for 90 minutes before and after PET scanning.
|
Moderate Intensity Exercise (50 % af VO2max) for 90 minutes
|
|
EXPERIMENTAL: Healthy female volunteers
Behavioral: Exercise Moderate Intensity Exercise (50 % af VO2max) for 90 minutes before and after PET scanning.
|
Moderate Intensity Exercise (50 % af VO2max) for 90 minutes
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The effect of physical activity on the heart's metabolism of fatty acids in obese with and without NAFLD
Time Frame: 2 years
|
Primary outcome: - Fatty acid uptake (mg/kg/min) in the Heart in obese with and without NAFLD |
2 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To determine the effect of an acute exercise bout on the improvement of cardiac FA utilization in obese with and without NAFLD.
Time Frame: 2 years
|
Fatty acid oxidation (µmol/min) in the Heart in obese with and without NAFLD.
|
2 years
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- jeyanrk
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.